ALX Oncology Holdings Inc. (ALXO)
NASDAQ·Healthcare·Biotechnology
$1.98
+3.95%
Mkt Cap $269.13M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$17.90
Range $1.50 – $38.00
Implied Upside
+806.3%
Consensus $17.90 vs current $1.98
NASDAQ·Healthcare·Biotechnology
$1.98
+3.95%
Mkt Cap $269.13M
No recent rating data.
Price Target (7 analysts)
$17.90
Range $1.50 – $38.00
+806.3%
Consensus $17.90 vs current $1.98